ClinicalTrials.gov
public full text
Public Domain
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis
The purpose of this study is to investigate similarity between NI-071 and infliximab(the comparator) in terms of efficacy in patients with Rheumatoid Arthritis not adequately responding to Methotrexate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)#888220
- Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.#873132
- First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis#877277
- Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis#1047013
- Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+#866709
Record · ID 912551
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive